Differential Use of Warfarin for Secondary Stroke Prevention in Patients With Various Types of Atrial Fibrillation

Anticoagulation therapy significantly reduces the incidence of thromboembolic events in patients with atrial fibrillation (AF), and warfarin therapy at discharge is a class I–indicated drug in patients with ischemic stroke with persistent or paroxysmal AF without contraindications. The aim was to de...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Lewis, William R., Fonarow, Gregg C., LaBresh, Kenneth A., Cannon, Christopher P., Pan, Wenqin, Super, Dennis M., Sorof, Suzanne A., Schwamm, Lee H.
Format: Artigo
Idioma:Inglês
Publicat: 2008
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086549/
https://ncbi.nlm.nih.gov/pubmed/19121441
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.amjcard.2008.08.062
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars